Ginkgo Bioworks Holdings Inc at Morgan Stanley Global Healthcare Conference Transcript
All right. Good morning, everyone. I'm Tejas Savant. I cover the Life Sciences space here at Morgan Stanley. Before we get started, for important disclosures, please see the Morgan Stanley research disclosure website at morganstanley.com/researchdisclosures. And if you have any questions, do reach out to your sales rep.
So it's my pleasure to host Ginkgo Bioworks today. And from the company, we have Anna Marie Wagner, Senior Vice President of Corporate Development. So thank you for joining us, Anna Marie.
Happy to be here.
Questions & Answers
Maybe just to kick things off, can you share some of Ginkgo's sort of key accomplishments over the course of the past year? And what are you most excited about as we head into 2024?
| Access to All Earning Calls and Stock Analysis | |
| 30-Year Financial on one screen | |
| All-in-one Stock Screener with unlimited filters | |
| Customizable Stock Dashboard | |
| Real Time Insider Trading Transactions | |
| 8,000+ Institutional investors’ 13F holdings | |
| Powerful Excel Add-in and Google sheets Add-on | |
| All data downloadable | |
| Quick customer support | |
| And much more... |
Trustpilot
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
